V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.
about
Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.Bioinformatic analysis of HIV-1 entry and pathogenesis.Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interactionThe antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rateConvergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progressionMutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family.Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution.Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses.Human immunodeficiency virus type 1 populations in blood and semen.Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rateGenetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmissionA group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressureRole of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropismCharacterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection.Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain.A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects.Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genesDivergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses.Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population.
P2860
Q24815687-E808355A-0B81-42D5-8652-38529D1C1B32Q27693321-59CB4747-A0C9-40B5-ADC6-E13E72218449Q28369689-8163C00C-4189-47C1-9AD1-2D41AB79C972Q28378929-DAE9CB68-6A49-4BB6-B872-C33BD8BAC5FDQ30416671-7381B452-9BE2-47CF-B70F-8AA7A96878E2Q30420728-28D7C7B6-59F5-4AD5-B0E6-F6FFA1735A5EQ30453467-B2D0332A-D017-4D6B-9BF5-3379B54B4A5EQ33328140-65F550CD-DD5A-4895-93AF-078CDB267FD0Q33369086-AA12697A-3D3B-4C8A-AF33-C5FFA620D8BFQ33509526-3A217A80-782C-4B09-BA15-90D259CF8D9EQ33558676-DA056F6D-AE61-4E42-9AF7-535668E52940Q33604959-793D8400-4F03-4620-8755-876B2154E723Q33645838-82D00DCC-490C-4DBC-B689-362620B8700DQ33646567-75F8E968-2894-41C0-BB70-2986EA57479DQ33755126-4F00D697-2250-4BBB-8F50-9988DF2B87DCQ33782102-AF7F5974-0319-44AE-87C2-47C241ACAC66Q33784748-4395CC61-A1CD-46D9-8561-0AD86BE97C23Q33785632-6EDB72AB-ABF1-451E-B0F0-87424F23E674Q33792878-BA5BD6F4-6C39-4714-A2E7-F4D66C8CCBB8Q33815193-A8889B6F-3F66-4A09-A4A3-F6699E1BEC08Q33816465-EE004D2B-B026-4A8D-9135-EBB25F63F8F7Q33874171-2B1646BD-D7CF-4745-A3CD-31C956A33AFDQ34280044-79C127A0-872B-40B9-A5CB-2322746DED6AQ34366008-1F37CBAF-AAF8-4CCF-9FAC-1C1F4165630DQ34647858-D7FBFC6D-AD2E-4707-8457-16BCB632C00AQ35580330-98A11194-86B5-4CCE-8815-47F0596FFF05Q35704022-C42438D6-1CC3-4E35-8E88-1EBAA9688E27Q35745432-C40DE35F-2E03-410A-9415-720B9669E527Q35828735-94EEDBC1-376D-4CA3-99B4-6F3885C705F8Q35828898-7E55BB24-E0CE-42A4-B358-374E1BD00285Q35838430-36FA74DC-CF5D-47AE-A1E0-B228BEAEF724Q35839969-938B24C2-7B47-4FC7-8F92-38ABC6B64ACBQ35846005-1391684F-C11F-4596-ABA4-46F6F973D6E3Q35848446-31A2A580-5D26-494C-B1CC-A442B472E50FQ35857907-96E66BB1-DDCC-426D-9A52-9877D2FEEC5DQ35871314-6BEAAEDE-A407-45B5-A3DC-F18D47DFB850Q35876927-22E870AA-5037-4FB0-9D1F-9DAF2D218499Q35886136-CD154152-F040-4F63-9A7B-243706E388E9Q35898952-6198BC0E-F2D3-43DD-BD15-FD058A716374Q36025234-0BA92E14-C603-4A24-B288-A3853D2D3B8B
P2860
V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
V3 loop of the human immunodef ...... rpreting sequence variability.
@en
type
label
V3 loop of the human immunodef ...... rpreting sequence variability.
@en
prefLabel
V3 loop of the human immunodef ...... rpreting sequence variability.
@en
P2093
P2860
P1433
P1476
V3 loop of the human immunodef ...... erpreting sequence variability
@en
P2093
P2860
P304
P407
P577
1993-09-01T00:00:00Z